Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Peripheral Intervention Drug-Eluting Devices Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Peripheral Intervention Drug-Eluting Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Plain Old Balloon Angioplasty (POBA)
      • 1.3.3 Percutaneous Transluminal Angioplasty (PTA)
    • 1.4 Market Segment by Application
      • 1.4.1 Global Peripheral Intervention Drug-Eluting Devices Market Share by Application (2019-2025)
      • 1.4.2 Drug-Eluting Balloons
      • 1.4.3 Drug-Eluting Stents
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Peripheral Intervention Drug-Eluting Devices Production Value 2014-2025
      • 2.1.2 Global Peripheral Intervention Drug-Eluting Devices Production 2014-2025
      • 2.1.3 Global Peripheral Intervention Drug-Eluting Devices Capacity 2014-2025
      • 2.1.4 Global Peripheral Intervention Drug-Eluting Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Peripheral Intervention Drug-Eluting Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Peripheral Intervention Drug-Eluting Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Peripheral Intervention Drug-Eluting Devices Capacity by Manufacturers
      • 3.1.2 Global Peripheral Intervention Drug-Eluting Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Peripheral Intervention Drug-Eluting Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Peripheral Intervention Drug-Eluting Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Peripheral Intervention Drug-Eluting Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Peripheral Intervention Drug-Eluting Devices Price by Manufacturers
    • 3.4 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Peripheral Intervention Drug-Eluting Devices Market
    • 3.6 Key Manufacturers Peripheral Intervention Drug-Eluting Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Plain Old Balloon Angioplasty (POBA) Production and Production Value (2014-2019)
      • 4.1.2 Percutaneous Transluminal Angioplasty (PTA) Production and Production Value (2014-2019)
    • 4.2 Global Peripheral Intervention Drug-Eluting Devices Production Market Share by Type
    • 4.3 Global Peripheral Intervention Drug-Eluting Devices Production Value Market Share by Type
    • 4.4 Peripheral Intervention Drug-Eluting Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Peripheral Intervention Drug-Eluting Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Peripheral Intervention Drug-Eluting Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Peripheral Intervention Drug-Eluting Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Peripheral Intervention Drug-Eluting Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Peripheral Intervention Drug-Eluting Devices Import & Export
    • 6.5 China
      • 6.5.1 China Peripheral Intervention Drug-Eluting Devices Production Growth Rate 2014-2019
      • 6.5.2 China Peripheral Intervention Drug-Eluting Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Peripheral Intervention Drug-Eluting Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Peripheral Intervention Drug-Eluting Devices Consumption by Regions

    • 7.1 Global Peripheral Intervention Drug-Eluting Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Peripheral Intervention Drug-Eluting Devices Consumption by Type
      • 7.2.2 United States Peripheral Intervention Drug-Eluting Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Peripheral Intervention Drug-Eluting Devices Consumption by Type
      • 7.3.2 European Union Peripheral Intervention Drug-Eluting Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Peripheral Intervention Drug-Eluting Devices Consumption by Type
      • 7.4.2 China Peripheral Intervention Drug-Eluting Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Peripheral Intervention Drug-Eluting Devices Consumption by Type
      • 7.5.2 Rest of World Peripheral Intervention Drug-Eluting Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Medtronic plc
      • 8.1.1 Medtronic plc Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.1.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.1.5 Medtronic plc Recent Development
    • 8.2 Boston Scientific Corporation
      • 8.2.1 Boston Scientific Corporation Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.2.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.2.5 Boston Scientific Corporation Recent Development
    • 8.3 Abbott Laboratories
      • 8.3.1 Abbott Laboratories Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.3.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.3.5 Abbott Laboratories Recent Development
    • 8.4 Cardinal Health
      • 8.4.1 Cardinal Health Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.4.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.4.5 Cardinal Health Recent Development
    • 8.5 B. Braun Melsungen AG
      • 8.5.1 B. Braun Melsungen AG Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.5.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.5.5 B. Braun Melsungen AG Recent Development
    • 8.6 Biosensors International Group Ltd.
      • 8.6.1 Biosensors International Group Ltd. Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.6.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.6.5 Biosensors International Group Ltd. Recent Development
    • 8.7 C.R. Bard, Inc.
      • 8.7.1 C.R. Bard, Inc. Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.7.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.7.5 C.R. Bard, Inc. Recent Development
    • 8.8 St. Jude Medical, Inc.
      • 8.8.1 St. Jude Medical, Inc. Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.8.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.8.5 St. Jude Medical, Inc. Recent Development
    • 8.9 The Lubrizol Corporation
      • 8.9.1 The Lubrizol Corporation Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.9.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.9.5 The Lubrizol Corporation Recent Development
    • 8.10 Terumo Corporation
      • 8.10.1 Terumo Corporation Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Peripheral Intervention Drug-Eluting Devices
      • 8.10.4 Peripheral Intervention Drug-Eluting Devices Product Introduction
      • 8.10.5 Terumo Corporation Recent Development

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Peripheral Intervention Drug-Eluting Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Peripheral Intervention Drug-Eluting Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Peripheral Intervention Drug-Eluting Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Peripheral Intervention Drug-Eluting Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Peripheral Intervention Drug-Eluting Devices Production Forecast by Type
      • 9.7.2 Global Peripheral Intervention Drug-Eluting Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Peripheral Intervention Drug-Eluting Devices Sales Channels
      • 10.2.2 Peripheral Intervention Drug-Eluting Devices Distributors
    • 10.3 Peripheral Intervention Drug-Eluting Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Drug eluting devices are devices that are coated with anti-proliferated agent. These devices exert antirestenotic efficacy on the vessel wall to remove the blockade within the blood vessels caused by deposition of plaque.
      In 2019, the market size of Peripheral Intervention Drug-Eluting Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Peripheral Intervention Drug-Eluting Devices.

      This report studies the global market size of Peripheral Intervention Drug-Eluting Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Peripheral Intervention Drug-Eluting Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Medtronic plc
      Boston Scientific Corporation
      Abbott Laboratories
      Cardinal Health
      B. Braun Melsungen AG
      Biosensors International Group Ltd.
      C.R. Bard, Inc.
      St. Jude Medical, Inc.
      The Lubrizol Corporation
      Terumo Corporation

      Market Segment by Product Type
      Plain Old Balloon Angioplasty (POBA)
      Percutaneous Transluminal Angioplasty (PTA)

      Market Segment by Application
      Drug-Eluting Balloons
      Drug-Eluting Stents

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Peripheral Intervention Drug-Eluting Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Peripheral Intervention Drug-Eluting Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Peripheral Intervention Drug-Eluting Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now